Literature DB >> 17634461

BCR-ABL tyrosine kinase inhibitors for chronic myelogenous leukemia.

Charles A Schiffer1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17634461     DOI: 10.1056/NEJMct071828

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  48 in total

Review 1.  Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine.

Authors:  Q Tian; N D Price; L Hood
Journal:  J Intern Med       Date:  2012-02       Impact factor: 8.989

2.  Blocking p55PIK signaling inhibits proliferation and induces differentiation of leukemia cells.

Authors:  G Wang; Y Deng; X Cao; S Lai; Y Tong; X Luo; Y Feng; X Xia; J Gong; J Hu
Journal:  Cell Death Differ       Date:  2012-06-22       Impact factor: 15.828

3.  The Neurobiology of Addiction: Where We Have Been and Where We Are Going.

Authors:  George F Koob; Eric J Simon
Journal:  J Drug Issues       Date:  2009-01

4.  Imatinib attenuates monocrotaline pulmonary hypertension and has potent vasodilator activity in pulmonary and systemic vascular beds in the rat.

Authors:  Edward A Pankey; Supat Thammasiboon; George F Lasker; Syed Baber; Joseph A Lasky; Philip J Kadowitz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-08-30       Impact factor: 4.733

5.  Charting the molecular network of the drug target Bcr-Abl.

Authors:  Marc Brehme; Oliver Hantschel; Jacques Colinge; Ines Kaupe; Melanie Planyavsky; Thomas Köcher; Karl Mechtler; Keiryn L Bennett; Giulio Superti-Furga
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-20       Impact factor: 11.205

6.  Quantitative in situ detection of phosphoproteins in fixed tissues using quantum dot technology.

Authors:  Juraj Bodo; Lisa Durkin; Eric D Hsi
Journal:  J Histochem Cytochem       Date:  2009-03-30       Impact factor: 2.479

Review 7.  Bringing cancer care to the poor: experiences from Rwanda.

Authors:  Lawrence N Shulman; Tharcisse Mpunga; Neo Tapela; Claire M Wagner; Temidayo Fadelu; Agnes Binagwaho
Journal:  Nat Rev Cancer       Date:  2014-10-30       Impact factor: 60.716

8.  New effective inhibitors of the Abelson kinase.

Authors:  George A Kraus; Vinayak Gupta; Marjan Mokhtarian; Samir Mehanovic; Marit Nilsen-Hamilton
Journal:  Bioorg Med Chem       Date:  2010-07-14       Impact factor: 3.641

9.  Diversity synthesis of complex pyridines yields a probe of a neurotrophic signaling pathway.

Authors:  B Lawrence Gray; Xiang Wang; W Colby Brown; Letian Kuai; Stuart L Schreiber
Journal:  Org Lett       Date:  2008-05-30       Impact factor: 6.005

10.  Dasatinib in the treatment of imatinib refractory chronic myeloid leukemia.

Authors:  Radhakrishnan Ramchandren; Charles A Schiffer
Journal:  Biologics       Date:  2009-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.